Medicare Enrolled
Dr. Hemalatha Vasireddy, MD
Hematology & Oncology · Belleville, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vasireddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vasireddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vasireddy
Dr. Hemalatha Vasireddy is a hematology & oncology specialist in Belleville, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vasireddy performed 41,553 Medicare services across 1,640 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vasireddy received a total of $6,888 from 68 pharmaceutical and/or device companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vasireddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in NJ
$6,888 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,553
Medicare services
Top 23% in NJ for hematology & oncology
1,640
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,078 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
30,000 | $1 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,120 | $6 | $16 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,410 | $0 | $0 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,149 | $69 | $177 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,006 | $8 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
994 | $8 | $17 |
| Anti-nausea injection (ondansetron/Zofran) | 768 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 640 | $1 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
618 | $105 | $287 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
272 | $26 | $71 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
258 | $12 | $33 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
222 | $121 | $321 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
161 | $110 | $296 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
156 | $59 | $154 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $79 | $208 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
117 | $14 | $38 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
100 | $60 | $156 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
90 | $26 | $68 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $141 | $380 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
71 | $1 | $3 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
70 | $143 | $402 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
56 | $11 | $32 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
41 | $2 | $6 |
| New patient office visit, complex (60-74 min) | 26 | $158 | $495 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
74.1% high complexity
15.6% medium
10.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,888
Total received (2018-2024)
Avg $984/year across 7 years
Top 35% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,124 (88.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$764 (11.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,799
2023
$1,121
2022
$555
2021
$353
2020
$462
2019
$1,356
2018
$1,242
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$230
Daiichi Sankyo Inc.
$186
E.R. Squibb & Sons, L.L.C.
$186
Janssen Biotech, Inc.
$165
Tempus AI, Inc
$83
Novartis Pharmaceuticals Corporation
$81
Aveo Pharmaceuticals, Inc.
$75
Merck Sharp & Dohme LLC
$60
GlaxoSmithKline, LLC.
$56
Bayer Healthcare Pharmaceuticals Inc.
$55
Regeneron Healthcare Solutions, Inc.
$54
ABBVIE INC.
$54
Celgene Corporation
$47
Eisai Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$38
BeiGene USA, Inc.
$35
PFIZER INC.
$34
EMD Serono, Inc.
$32
PUMA BIOTECHNOLOGY, INC.
$30
Acrotech Biopharma Inc.
$29
Acera Surgical, Inc.
$26
GENZYME CORPORATION
$22
Adaptive Biotechnologies Corporation
$20
Dendreon Pharmaceuticals LLC
$20
Karyopharm Therapeutics Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
Exelixis Inc.
$17
Genmab U.S., Inc.
$17
Genentech USA, Inc.
$17
Kyowa Kirin, Inc.
$16
SpringWorks Therapeutics, Inc.
$15
ImmunoGen, Inc.
$14
Rigel Pharmaceuticals, Inc.
$10
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$894
Novartis Pharmaceuticals Corporation
$602
E.R. Squibb & Sons, L.L.C.
$527
Daiichi Sankyo Inc.
$424
Seagen Inc.
$301
Janssen Biotech, Inc.
$282
Celgene Corporation
$274
Amgen Inc.
$253
PFIZER INC.
$221
Bayer HealthCare Pharmaceuticals Inc.
$161
Incyte Corporation
$150
Karyopharm Therapeutics Inc.
$145
Lilly USA, LLC
$135
Alexion Pharmaceuticals, Inc.
$109
Puma Biotechnology, Inc.
$108
Merck Sharp & Dohme Corporation
$106
Regeneron Healthcare Solutions, Inc.
$100
Merck Sharp & Dohme LLC
$95
EISAI INC.
$92
BeiGene USA, Inc.
$89
GlaxoSmithKline, LLC.
$88
Foundation Medicine, Inc.
$88
Genentech USA, Inc.
$88
Pharmacyclics LLC, An AbbVie Company
$86
Tempus AI, Inc
$83
Takeda Pharmaceuticals U.S.A., Inc.
$80
Aveo Pharmaceuticals, Inc.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$73
Eisai Inc.
$71
GENZYME CORPORATION
$67
Bayer Healthcare Pharmaceuticals Inc.
$55
ABBVIE INC.
$54
ASD SPECIALTY HEALTHCARE, LLC
$54
Exelixis Inc.
$53
Astellas Pharma US Inc
$52
Ipsen Biopharmaceuticals, Inc
$47
Otsuka America Pharmaceutical, Inc.
$46
CTI BioPharma Corp.
$44
Advanced Accelerator Applications
$41
Gilead Sciences, Inc.
$39
AMAG Pharmaceuticals, Inc.
$38
EMD Serono, Inc.
$32
Janssen Pharmaceuticals, Inc
$30
PUMA BIOTECHNOLOGY, INC.
$30
Acrotech Biopharma Inc.
$29
Blue Earth Diagnostics Limited
$28
Acera Surgical, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$24
Adaptive Biotechnologies Corporation
$20
Dendreon Pharmaceuticals LLC
$20
Sirtex Medical Inc
$19
Pharmacosmos Therapeutics Inc.
$18
Genmab U.S., Inc.
$17
Kyowa Kirin, Inc.
$16
SpringWorks Therapeutics, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$15
Global Blood Therapeutics, Inc.
$15
ImmunoGen, Inc.
$14
G1 Therapeutics, Inc.
$14
Stemline Therapeutics Inc.
$14
Pharmacyclics LLC, an AbbVie Company
$14
Kite Pharma, Inc.
$14
TESARO, Inc.
$13
Servier Pharmaceuticals LLC
$13
Mylan Pharmaceuticals Inc.
$13
Verastem, Inc.
$12
Clovis Oncology, Inc.
$10
Rigel Pharmaceuticals, Inc.
$10
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · Abraxane · Aliqopa · Axumin · BELEODAQ · BENDEKA · BOSULIF · BRUKINSA · Balversa · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELAHERE · ELIQUIS · ENHERTU · EPKINLY · Enhertu · Epkinly · FASLODEX · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Polivy · Poteligeo · Prolia · REBLOZYL · RETEVMO · RYDAPT · Restrata Wound Matrix · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Truxima · ULTOMIRIS · Ultomiris · VERZENIO · VOTRIENT · Vanflyta · Vitrakvi · Vonjo · XARELTO · XPOVIO · XTANDI · Xofigo · Xtandi · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
702
Per 100K population
82.2
County median income
$76,712
Nearest hospital
CLARA MAASS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vasireddy is a mixed practice specialist, with above-average Medicare volume (top 23% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vasireddy experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Vasireddy performed 30,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vasireddy receive payments from pharmaceutical companies?
Yes. Dr. Vasireddy received a total of $6,888 from 68 companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vasireddy's costs compare to other hematology & oncology specialists in Belleville?
Dr. Vasireddy's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vasireddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Belleville
Browse hematology & oncology specialists in Belleville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology